<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Prevalence of aortic regurgitation is increased with dexfenfluramine</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Prevalence of aortic regurgitation is increased with dexfenfluramine</h1>
<div class="graphic"><div class="figure"><div class="ttl">Prevalence of aortic regurgitation is increased with dexfenfluramine</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Among 223 patients treated with dexfenfluramine (Dexfen), there is an increase in the presence of 2+ aortic regurgitation (AR) (6.3 versus 1.6 percent for control, p&lt;0.02*) and any degree of AR (21.5 versus 11 percent, p = 0.005•). Additionally, there is a significant increase in any FDA-grade regurgitation of either the aortic or mitral valve in the dexfenfluramine patients (7.6 versus 2 percent, p = 0.01Δ).</div><div class="graphic_reference">Data from Shively BK, Roldan CA, Gill EA, et al. Circulation 1999; 100:2161.</div><div id="graphicVersion">Graphic 57538 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
